Literature DB >> 12743710

High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR.

Nicolas W J Schröder1, Corinna Hermann, Lutz Hamann, Ulf B Göbel, Thomas Hartung, Ralf R Schumann.   

Abstract

The recently described family of Toll-like receptors (TLRs) plays a major role in innate immunity by mediating inflammatory reactions against a wide array of pathogens. TLR-2 is reported to interact with various bacterial partial structures including lipoproteins, peptidoglycan, and lipoteichoic acid. Two polymorphisms of the TLR-2 gene have recently been described: Arg753Gln, correlated with the incidence of sepsis in a white population, and Arg677Trp, correlated with the incidence of lepromatous leprosy in an Asian population. Both polymorphisms, when inserted into expression vectors encoding for human TLR-2, reduced stimulation of Chinese hamster ovary cells by synthetic lipopeptides. We furthermore developed a rapid and inexpensive method for the detection of both single nucleotide polymorphisms based on restriction fragment length polymorphism. While no individuals carrying the Arg677Trp SNP were identified in a large group of whites, 9.4% of the study population were found to be heterozygous for the Arg753Gln polymorphism. This ratio is significantly higher than previously reported, and therefore detection of this polymorphism among patients may yield important information for the assessment of risk profiles regarding susceptibility to bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743710     DOI: 10.1007/s00109-003-0443-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  21 in total

1.  Determination of the TLR4 genotype using allele-specific PCR.

Authors:  E Lorenz; K L Frees; D A Schwartz
Journal:  Biotechniques       Date:  2001-07       Impact factor: 1.993

Review 2.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

3.  Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi.

Authors:  R Mark Wooten; Ying Ma; R Alyson Yoder; Jeanette P Brown; John H Weis; James F Zachary; Carsten J Kirschning; Janis J Weis
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

4.  Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections.

Authors:  Doreen M Agnese; Jacqueline E Calvano; Sae J Hahm; Susette M Coyle; Siobhan A Corbett; Steve E Calvano; Stephen F Lowry
Journal:  J Infect Dis       Date:  2002-10-29       Impact factor: 5.226

5.  Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.

Authors:  T K Means; S Wang; E Lien; A Yoshimura; D T Golenbock; M J Fenton
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

6.  Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.

Authors:  R Schwandner; R Dziarski; H Wesche; M Rothe; C J Kirschning
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

7.  Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock.

Authors:  Eva Lorenz; Jean Paul Mira; Kathy L Frees; David A Schwartz
Journal:  Arch Intern Med       Date:  2002-05-13

8.  A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection.

Authors:  E Lorenz; J P Mira; K L Cornish; N C Arbour; D A Schwartz
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

9.  Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness.

Authors:  Naoko Okayama; Kozue Fujimura; Yutaka Suehiro; Yuichiro Hamanaka; Motoki Fujiwara; Tomoyo Matsubara; Tsuyoshi Maekawa; Shoichi Hazama; Masaaki Oka; Hiroaki Nohara; Kozo Kayano; Kiwamu Okita; Yuji Hinoda
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

10.  Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling.

Authors:  Pierre-Yves Bochud; Thomas R Hawn; Alan Aderem
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

View more
  46 in total

1.  Different patterns of Toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins.

Authors:  M Ioana; B Ferwerda; T S Plantinga; M Stappers; M Oosting; M McCall; A Cimpoeru; F Burada; N Panduru; R Sauerwein; O Doumbo; J W M van der Meer; R van Crevel; L A B Joosten; M G Netea
Journal:  Infect Immun       Date:  2012-02-21       Impact factor: 3.441

2.  Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria.

Authors:  Frank P Mockenhaupt; Jakob P Cramer; Lutz Hamann; Miriam S Stegemann; Jana Eckert; Na-Ri Oh; Rowland N Otchwemah; Ekkehart Dietz; Stephan Ehrhardt; Nicolas W J Schröder; Ulrich Bienzle; Ralf R Schumann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

3.  TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children.

Authors:  Afig Berdeli; Handan Ak Celik; Ruhi Ozyürek; Buket Dogrusoz; Hikmet Hakan Aydin
Journal:  J Mol Med (Berl)       Date:  2005-06-21       Impact factor: 4.599

4.  High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus.

Authors:  Fang F Yuan; Ingrid Boehm; Paul K S Chan; Katherine Marks; Julian W Tang; David S C Hui; Joseph J Y Sung; Wayne B Dyer; Andrew F Geczy; John S Sullivan
Journal:  Clin Vaccine Immunol       Date:  2007-10-03

5.  Toll-like receptors TLR4 (Asp299Gly and Thr399Ile) and TLR2 (Arg677Trp and Arg753Gln) gene polymorphisms in end-stage renal disease patients on peritoneal dialysis.

Authors:  Kamini Singh; Kashi Nath Prasad; Priyanka Mishra; Jahanarah Khatoon; Narayan Prasad; Amit Gupta; Janmejai Kumar Srivastava
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

6.  Heterozygous toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and inflammatory responses.

Authors:  Sonja von Aulock; Nicolas W J Schröder; Stephanie Traub; Katja Gueinzius; Eva Lorenz; Thomas Hartung; Ralf R Schumann; Corinna Hermann
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

7.  Lack of Toll-like receptor 4 and 2 polymorphisms in Korean patients with bacteremia.

Authors:  Hee Jung Yoon; Jun Yong Choi; Chang Oh Kim; Yoon Seon Park; Myoung Soo Kim; Young Keun Kim; So Youn Shin; June Myung Kim; Young Goo Song
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

8.  Toll-like receptors 2 and 4 and their mutations in patients with otitis media and middle ear effusion.

Authors:  Young Chan Lee; Chul Kim; Ju Sup Shim; Jae Yong Byun; Mun Suh Park; Chang Il Cha; Young Il Kim; Jin Woo Lee; Seung Geun Yeo
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-12-26       Impact factor: 3.372

9.  Toll-like receptor polymorphisms in malaria-endemic populations.

Authors:  Jennifer A Greene; Ann M Moormann; John Vulule; Moses J Bockarie; Peter A Zimmerman; James W Kazura
Journal:  Malar J       Date:  2009-03-24       Impact factor: 2.979

10.  TLR2 polymorphisms, Arg753Gln and Arg677Trp, are not associated with increased burden of tuberculosis in Indian patients.

Authors:  Debasis Biswas; Shailendra K Gupta; Girish Sindhwani; Abhishek Patras
Journal:  BMC Res Notes       Date:  2009-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.